XpressBio Launches Cutting-Edge Cas9 ELISA Assay - An Essential Tool for Monitoring Cas9 Protein Levels in Cell Lines
FREDERICK, Md., July 22, 2019 /PRNewswire-PRWeb/ -- XpressBio, a small business leader in Life Science Research products, has launched an ELISA assay that can quantitatively detect levels of the Cas9 protein in cell culture. Knowing precise levels of the Cas9 protein in cell lines gives researchers valuable data to utilize for gene editing studies. After seeing the demand for a quality, reliable tool-to-monitor Cas9 in the rapid field of genetic engineering, XpressBio scientists developed the Cas9 ELISA to provide a favorable solution.
"The Cas9 endonuclease is a critical and essential component of the CRISPR/Cas9 gene editing system. Therefore, it is of great importance to evaluate the abundance of Cas9 in systems that utilize this technology. The XpressBio Cas9 ELISA has many functional applications including, but not limited to, evaluation of transfection efficiency, monitoring of Cas9 within stable cell systems, and troubleshooting of the CRISPR/Cas9 system in the event gene knock-out or transgene incorporation isn't achieved. From start to finish the Cas9 ELISA can be performed in ~3 hours, making this assay incredibly efficient and convenient for the end user as compared to most other methodologies." -Walter Baseler, Ph.D., Scientific Developer.
About XpressBio
Based out of Frederick, MD, XpressBio manufactures and markets products for research use in the Life Sciences field. They got their start in the Laboratory Animal Health Monitoring industry in 2003, and have since expanded their portfolio to more than 7,000 products. With customers in over 30 countries, including government agencies, academic institutes, and private companies, XpressBio strives to be a front-leader by offering customizable laboratory solutions.
SOURCE XpressBio
